Qvar
(Beclomethasone)PreclinicalSmall molecule
Chiesi Farmaceutici S.p.A.Beclomethasone is an inhaled or nasal corticosteroid used to prevent and treat asthma symptoms and reduce nasal inflammation from allergies or nasal polyps.[1] Qvar is currently being investigated across 4 indications[3], with its most advanced program in Preclinical.[1]
Qvar is one of 122 small molecule programs targeting Chronic Obstructive Pulmonary Disease. It is currently in Preclinical.
4
Indications
23
Total Trials
1
Active Trials
121
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
120 competitors in Chronic Obstructive Pulmonary Disease
#DrugCompanyPhaseTrials
1EXDENSUR
GGlaxo Dba Glaxosmithkline
Phase 3
Lunsekimig
SanofiPhase 3
Tozorakimab
AstraZenecaPhase 3
CM310
KKeymed Biosciences Co.Ltd
Phase 3
Sildenafil ODT
PPfizer's Upjohn has merged with Mylan to form Viatris Inc.
Phase 2
Astegolimab
RochePhase 3
Titrated Oxygen
RRigshospitalet, Denmark
Phase 3
HSK39004
Haisco Pharmaceutical Group Co., Ltd.Phase 2
Qvar
Chiesi Farmaceutici S.p.A.Preclinical
Calciferol
Jazz PharmaceuticalsPreclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Asthma8 trials
Show 5 more trials
Wheezing2 trials
Treatment2 trials
Directed Topical Drug Delivery for Treatment for PASC Hyposmia
Completed·—·Phase 2·NCT05970731·16 enrolled
8 more indications
Chronic Graft Versus Host Disease1 trial
Vitiligo1 trial
Betamethasone Phonophoresis For Vitiligo
Recruiting·—·N/A·NCT07267273·60 enrolled
Dyspnea1 trial
THL1 trial
Beclomethasone in Healthy Athletes
Unknown status·—·Phase 4·NCT05352191·30 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Beclomethasone. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company